Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Adults With MS, Comorbidities Shoulder Significant Economic, Health Burdens
June 11th 2021The study authors hope their findings inform future interventions whose goal is to minimize the comorbidity burden of adults with multiple sclerosis (MS), thereby improving their quality of life and ultimate health outcomes.
Read More
Lower Risk of Relapse Seen Among UK Children With RRMS Receiving Newer DMTs
June 9th 2021Compared with their peers receiving injectable treatments for their relapsing-remitting multiple sclerosis (RRMS), children who received newer disease-modifying therapies (DMTs) had improved scores on several measures of disease progression.
Read More
Elderly Patients With Heart Failure May Benefit From Progressive Rehabilitation
June 8th 2021Progressive rehabilitation produced superior results among patients randomized to a 36-session program during or following hospitalization for acute decompensated heart failure vs those randomized to usual care.
Read More
A Q&A With HIV/AIDS Pioneer Dr Michael Gottlieb
June 4th 2021This week marks the 40th anniversary of the CDC's June 5, 1981, Morbidity and Mortality Weekly Report describing rare instances of immunocompromised status among 5 homosexual men in Los Angeles. The American Journal of Managed Care® spoke recently with lead author Michael Gottlieb, MD, who was the first to describe what would come to be known as HIV and AIDS.
Read More
The Search for an HIV Vaccine Continues
May 18th 2021May 18 is HIV Vaccine Awareness Day. Here we explore just a few of the many reasons why a vaccine that is effective at preventing the acquisition of HIV and at reducing the viral load in those currently living with HIV remains an elusive goal.
Read More
AHF Management Among Elderly, Super-Elderly Needs Improvement in Japan
May 15th 2021Rates of acute heart failure (AHF) have recently been rapidly increasing among elderly and super-elderly patients in Japan, and this study investigated rates of all-cause death and mode of death among this patient population.
Read More
Studies With Potential to Change the Science of Heart Failure Management
May 14th 2021These 4 studies were pegged as “ones to watch” during the American College of Cardiology (ACC) annual briefing on results for consumers. They will be presented in the opening session of late-breaking clinical trial results on day 1 of ACC.21.
Read More
Recent Gains for Patients With POMS Linked to Therapeutic, Disease Management Advancements
May 7th 2021Although knowledge is plentiful on disease state improvements for adult patients with multiple sclerosis (MS) following use of newer disease-modifying therapies, less is known about similar outcomes among patients with pediatric-onset MS (POMS).
Read More
B-Cell Depletion May Indicate Reduced COVID-19 Antibody Response Among Patients With MS
May 3rd 2021New research demonstrates that patients with multiple sclerosis (MS) who were asymptomatic for COVID-19 had lower antibody levels against SARS-CoV-2, its causative virus, due to having fewer B cells.
Read More
DMT Uptake, Prescriptions Not Fitting Disease Course Among Patients With MS
April 30th 2021Because real-world data are lacking on disease-modifying treatment (DMT) prescribing patterns for patients with multiple sclerosis (MS), a team of investigators wanted to make sure these individuals were receiving adequate care.
Read More
Concentrated HIV, STI Epidemics Stress Public Health Care Need Among Black Women
April 29th 2021Disproportionate rates of HIV and sexually transmitted infections (STIs) among Black women, who have a nearly 4 times higher enrollment rate in community supervision programs, underscores the need for culturally targeted HIV/STI interventions.
Read More
Accurately Identifying Heart Failure in Patients With COPD
April 22nd 2021A new approach to identifying and defining heart failure among patients with chronic obstructive pulmonary disease (COPD) involves combining information gleaned from reviewing their electronic medical records and examination charts.
Read More
MS Patients on Ocrelizumab May Have Lessened Immune Response to SARS-CoV-2
April 21st 2021In an abstract presented at this year’s American Academy of Neurology annual meeting, patients with multiple sclerosis (MS) taking ocrelizumab had less of an immune reaction to infection with SARS-CoV-2, the virus that causes COVID-19.
Read More
DMT Alone Not a Good Predictor of COVID-19 Among Patients With MS
April 19th 2021Compared with disease-modifying therapy (DMT), age, insurance status, and Hispanic ethnicity were shown to more accurately predict likelihood of COVID-19 and hospitalization from it among individuals with multiple sclerosis (MS).
Read More